Treatment of pancreatic ductal adenocarcinoma with tumor antigen specific-targeted delivery of paclitaxel loaded PLGA nanoparticles

Early detection of pancreatic cancer in mouse models using a novel antibody, TAB004

(2018) Shu-ta Wu et al.   PLoS One

Development of hematin conjugated PLGA nanoparticle for selective cancer targeting

(2016) Md. Lutful Amin et al.   EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES

Mucin-1-Antibody-Conjugated Mesoporous Silica Nanoparticles for Selective Breast Cancer Detection in a Mucin-1 Transgenic Murine Mouse Model

(2016) Didier Dréau et al.   Journal of Biomedical Nanotechnology

A novel association of neuropilin-1 and MUC1 in pancreatic ductal adenocarcinoma: role in induction of VEGF signaling and angiogenesis

(2016) R Zhou et al.   ONCOGENE

Antibody-Guided In Vivo Imaging for Early Detection of Mammary Gland Tumors

(2016) Laura Jeffords Moore et al.   Translational Oncology

Ultrasound-Mediated Microbubble Destruction (UMMD) Facilitates the Delivery of CA19-9 Targeted and Paclitaxel Loaded mPEG-PLGA-PLL Nanoparticles in Pancreatic Cancer

(2016) Lingxi Xing et al.   Theranostics

Anti-tumor Efficiency of Lipid-coated Cisplatin Nanoparticles Co-loaded with MicroRNA-375

(2016) Tan Yang et al.   Theranostics

Cancer statistics, 2015

(2015) Rebecca L. Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Human Pancreatic Cancer Tumors Are Nutrient Poor and Tumor Cells Actively Scavenge Extracellular Protein

(2015) J. J. Kamphorst et al.   CANCER RESEARCH

Current Approaches for Improving Intratumoral Accumulation and Distribution of Nanomedicines

(2015) Mikhail O Durymanov et al.   Theranostics

PLGA-Based Nanoparticles as Cancer Drug Delivery Systems

(2014) Fatemeh Sadat Tabatabaei Mirakabad et al.   Asian Pacific Journal of Cancer Prevention

The complex landscape of pancreatic cancer metabolism

(2014) C. M. Sousa et al.   CARCINOGENESIS

Does the Use of Neoadjuvant Therapy for Pancreatic Adenocarcinoma Increase Postoperative Morbidity and Mortality Rates?

(2014) Amanda B. Cooper et al.   JOURNAL OF GASTROINTESTINAL SURGERY

Nanotheranostics ˗ Application and Further Development of Nanomedicine Strategies for Advanced Theranostics

(2014) Madaswamy S. Muthu et al.   Theranostics

Cancer nanotechnology: The impact of passive and active targeting in the era of modern cancer biology

(2013) Nicolas Bertrand et al.   ADVANCED DRUG DELIVERY REVIEWS

Tumor extracellular acidity-activated nanoparticles as drug delivery systems for enhanced cancer therapy

(2013) Jin-Zhi Du et al.   BIOTECHNOLOGY ADVANCES

Biodistribution and bioimaging studies of hybrid paclitaxel nanocrystals: Lessons learned of the EPR effect and image-guided drug delivery

(2013) Christin P. Hollis et al.   JOURNAL OF CONTROLLED RELEASE

The use of a novel MUC1 antibody to identify cancer stem cells and circulating MUC1 in mice and patients with pancreatic cancer

(2013) Jennifer M. Curry et al.   JOURNAL OF SURGICAL ONCOLOGY

Indocyanine green-loaded biodegradable tumor targeting nanoprobes for in vitro and in vivo imaging

(2012) Cuifang Zheng et al.   BIOMATERIALS

PLGA-based nanoparticles: An overview of biomedical applications

(2012) Fabienne Danhier et al.   JOURNAL OF CONTROLLED RELEASE

The role of stroma in pancreatic cancer: diagnostic and therapeutic implications

(2012) Mert Erkan et al.   Nature Reviews Gastroenterology & Hepatology

nab -Paclitaxel Potentiates Gemcitabine Activity by Reducing Cytidine Deaminase Levels in a Mouse Model of Pancreatic Cancer

(2012) Kristopher K. Frese et al.   Cancer Discovery

Survival after Resection of Pancreatic Adenocarcinoma: Results from a Single Institution over Three Decades

(2011) Jordan M. Winter et al.   ANNALS OF SURGICAL ONCOLOGY

Aptamer-functionalized PEG–PLGA nanoparticles for enhanced anti-glioma drug delivery

(2011) Jianwei Guo et al.   BIOMATERIALS

Pancreatic Ductal Adenocarcinoma Mice Lacking Mucin 1 Have a Profound Defect in Tumor Growth and Metastasis

(2011) D. M. Besmer et al.   CANCER RESEARCH

Gemcitabine Plusnab-Paclitaxel Is an Active Regimen in Patients With Advanced Pancreatic Cancer: A Phase I/II Trial

(2011) Daniel D. Von Hoff et al.   JOURNAL OF CLINICAL ONCOLOGY

Biodegradable nanoparticles are excellent vehicle for site directed in-vivo delivery of drugs and vaccines

(2011) Anil Mahapatro et al.   JOURNAL OF NANOBIOTECHNOLOGY

Nanomedicinal strategies to treat multidrug-resistant tumors: current progress

(2010) Xiaowei Dong et al.   Nanomedicine

MUC1 enhances invasiveness of pancreatic cancer cells by inducing epithelial to mesenchymal transition

(2010) L D Roy et al.   ONCOGENE

Engineering of self-assembled nanoparticle platform for precisely controlled combination drug therapy

(2010) N. Kolishetti et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Internalization of MUC1 by anti-MUC1 antibody from cell membrane through the macropinocytotic pathway

(2009) Akinori Hisatsune et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

The Prioritization of Cancer Antigens: A National Cancer Institute Pilot Project for the Acceleration of Translational Research

(2009) M. A. Cheever et al.   CLINICAL CANCER RESEARCH

Structure and Function of the Cell Surface (Tethered) Mucins

(2007) Christine L. Hattrup et al.   Annual Review of Physiology